Thomas Pålsson
Vermögen: 40 598 $ am 31.05.2026
Vermögen: 40 598 $ am 31.05.2026
Thomas Pålsson currently works at Monivent AB, as Chief Financial Officer, Fullriggaren Konsult AB, as Chief Financial Officer, and Besattningen 1 Kommanditbolag, as Owner & Procurator.
Mr. Pålsson also formerly worked at Arexis AB, as Chief Financial Officer, Stayble Therapeutics AB, as Chief Financial Officer from 2018 to 2024, CirChem AB, as Chief Financial Officer from 2020 to 2024, Integrum AB, as Chief Financial Officer, and Toleranzia AB, as Chief Financial Officer from 2023 to 2024.
Mr. Pålsson received his graduate degree and Masters Business Admin degree from Handelshögskolan i Göteborg.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GARO AB
GARO AB Electrical ProductsProducer Manufacturing Develops, manufactures and markets products for the electrical installation market 0,05 % | 30.09.2025 | 26.510 ( 0,05 % ) | 40 598 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MONIVENT AB | Finanzdirektor/CFO | - |
Fullriggaren Konsult AB | Finanzdirektor/CFO | - |
Besattningen 1 Kommanditbolag | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Finanzdirektor/CFO | 01.08.2024 |
| TOLERANZIA AB | Finanzdirektor/CFO | 26.07.2024 |
| CIRCHEM AB | Finanzdirektor/CFO | 01.07.2024 |
| INTEGRUM AB | Finanzdirektor/CFO | 09.10.2019 |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Toleranzia AB
Toleranzia AB BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for the treatment of autoimmune orphan diseases | Health Technology |
Monivent AB
Monivent AB Medical SpecialtiesHealth Technology Develops device to monitor manual ventilation given to newborns unable to breathe | Health Technology |
Integrum AB
Integrum AB Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
Fullriggaren Konsult AB | |
CirChem AB
CirChem AB Chemicals: Major DiversifiedProcess Industries Produces chemical products | Process Industries |
Besattningen 1 Kommanditbolag |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen